Hutchinson Center as Lead Academic Participating Site (U10)

哈钦森中心作为主要学术参与地点 (U10)

• 批准号: 9031739
• 负责人: FREDERICK APPELBAUM
• 金额: $ 54.16万
• 依托单位: FRED HUTCHINSON CANCER RESEARCH CENTER
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-05-20 至 2019-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9031739
• 关键词: Adult; Alaska; American College of Radiology Imaging Network; Appointment; Area; Cancer Center; Cancer Hospital; Child; Clinical; Clinical Research; Clinical Trials; Clinical Trials Network; Conduct Clinical Trials; Country; Development; Diagnosis; Disease; Educational process of instructing; Enrollment; Faculty; Fred Hutchinson Cancer Research Center; Goals; Health; Idaho; Image; Individual; Institution; Joints; Lead; Leadership; Malignant Neoplasms; Mission; Montana; NCI Center for Cancer Research; National Clinical Trials Network; Occupational activity of managing finances; Pacific Northwest; Patients; Research; Research Infrastructure; Services; Shapes; Site; Southwest Oncology Group; Structure; System; Time; United States; Universities; Washington; Work; Wyoming; anticancer research; base; cancer care; cancer prevention; cancer therapy; clinical care; health care service organization; innovation; insight; member; next generation; novel strategies; organizational structure; pre-clinical; programs; research study

DESCRIPTION (provided by applicant): The goal of the NCI National Clinical Trials Network (NCTN) is to develop and conduct state-of-the-art cancer treatment and advanced imaging clinical trials, especially large, definitive multi-institutional trials evaluating new cancer therpies and related clinical approaches. NCTN Lead Academic Participating Sites (LAPS) are one component of this network and will provide scientific leadership in the development and conduct of NCTN clinical trials in association with one or more adult Network Groups as well as substantial accrual to clinical trials conducted across the entire NTCN. The Fred Hutchinson Cancer Research Center (FHCRC) is among the nation's leading cancer centers and is the only NCI-designated comprehensive cancer research center serving the WWAMI (Washington, Wyoming, Alaska, Montana and Idaho) region. The broad and deep pre-clinical and clinical research programs at the FHCRC will support the NCTN Program in three major ways: (1) The scientific expertise of the members of the FHCRC will continue to contribute to the leadership of the NCTN program through their activities directly at the NCI and in SWOG, NRG and ACRIN. (2) The innovative pre-clinical and clinical research studies at the FHCRC will provide the preliminary information necessary to shape the next generation of cooperative group trials. (3) The large patient base at the FHCRC combined with expert clinicians and clinical trials infrastructure will assure substantial accrual to NCTN trials. Fred Hutchinson Cancer Research Center and its partners are committed to the goals of the National Clinical Trials Network (NCTN) and will work to provide leadership for our nation's clinical trials network.

NCI国家临床试验网络（NCTN）的目标是开发和进行最先进的癌症治疗和先进的成像临床试验，特别是大型，确定性的多机构试验，评估新的癌症疗法和相关的临床方法。NCTN牵头学术参与研究中心（LAPS）是该网络的一个组成部分，将在与一个或多个成人网络组相关的NCTN临床试验的开发和实施中提供科学领导，并为整个NTCN开展的临床试验提供实质性支持。弗雷德哈钦森癌症研究中心（FHCRC）是美国领先的癌症中心之一，也是唯一一家服务于WWAMI（华盛顿、怀俄明州、阿拉斯加、蒙大拿和爱达荷州）地区的NCI指定的综合性癌症研究中心。FHCRC广泛而深入的临床前和临床研究计划将以三种主要方式支持NCTN计划：（1）FHCRC成员的科学专业知识将继续通过他们直接在NCI和SWOG，NRG和ACRIN的活动为NCTN计划的领导做出贡献。(2)FHCRC的创新性临床前和临床研究将为塑造下一代合作组试验提供必要的初步信息。(3)FHCRC的庞大患者基础与专家临床医生和临床试验基础设施相结合，将确保NCTN试验的大量增加。弗雷德哈钦森癌症研究中心及其合作伙伴致力于国家临床试验网络（NCTN）的目标，并将努力为我们国家的临床试验网络提供领导。